Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Combination Chemotherapy, Radiation Therapy Could Increase Survival
October 4th, 2001
A systematic review of randomized trials in the past two decades published in the September 8, 2001 issue of The Lancet concludes that women given concurrent chemotherapy and radiotherapy for cervical cancer could have an increased survival rate compared with patients treated with radiotherapy alone. Cervical cancer is the second most common cancer affecting women, and is the main cause of cancer mortality in less-developed countries. Around 80% of women are treated with radiotherapy alone; however, the chemotherapeutic agent cisplatin is effective for treating metastatic cervical cancer, and is thought to enhance the effects of radiotherapy. ...
Source: Women's Health Weekly (2001-10-04)
|
